Molina Healthcare (NYSE:MOH) Price Target Lowered to $412.00 at TD Cowen

Molina Healthcare (NYSE:MOH) had its price target decreased by TD Cowen from $453.00 to $412.00 in a research report report published on Tuesday morning, Benzinga reports. TD Cowen currently has a buy rating on the stock.

Several other brokerages have also recently commented on MOH. Barclays reduced their price target on shares of Molina Healthcare from $437.00 to $430.00 and set an equal weight rating on the stock in a research report on Thursday, April 25th. Wells Fargo & Company decreased their target price on Molina Healthcare from $410.00 to $375.00 and set an equal weight rating for the company in a research report on Monday, April 29th. Cantor Fitzgerald reiterated an overweight rating and issued a $406.00 price target on shares of Molina Healthcare in a report on Thursday, April 4th. Truist Financial raised their price objective on Molina Healthcare from $435.00 to $460.00 and gave the stock a buy rating in a research note on Tuesday, February 20th. Finally, Stephens reiterated an equal weight rating and set a $390.00 target price on shares of Molina Healthcare in a research note on Thursday, April 25th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $398.55.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $339.68 on Tuesday. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare has a fifty-two week low of $266.35 and a fifty-two week high of $423.92. The business has a 50 day moving average price of $384.15 and a two-hundred day moving average price of $371.76. The firm has a market cap of $19.91 billion, a PE ratio of 18.43, a price-to-earnings-growth ratio of 1.04 and a beta of 0.54.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping analysts’ consensus estimates of $5.46 by $0.27. The business had revenue of $9.93 billion during the quarter, compared to the consensus estimate of $9.45 billion. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The business’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same quarter last year, the company earned $5.81 earnings per share. Sell-side analysts expect that Molina Healthcare will post 23.59 earnings per share for the current fiscal year.

Insider Transactions at Molina Healthcare

In related news, Director Richard M. Schapiro sold 1,000 shares of Molina Healthcare stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the sale, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the transaction, the chief financial officer now owns 36,531 shares in the company, valued at approximately $14,121,423.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard M. Schapiro sold 1,000 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the completion of the transaction, the director now directly owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Over the last quarter, insiders sold 16,711 shares of company stock worth $6,472,517. Insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Institutional investors have recently bought and sold shares of the stock. WBI Investments LLC bought a new stake in shares of Molina Healthcare during the 1st quarter worth about $621,000. Team Hewins LLC bought a new stake in Molina Healthcare during the first quarter worth approximately $204,000. Mediolanum International Funds Ltd acquired a new stake in Molina Healthcare in the first quarter worth approximately $9,911,000. BI Asset Management Fondsmaeglerselskab A S boosted its stake in Molina Healthcare by 69.5% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 11,809 shares of the company’s stock valued at $4,851,000 after purchasing an additional 4,840 shares in the last quarter. Finally, Quent Capital LLC increased its position in shares of Molina Healthcare by 6.8% during the 1st quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after purchasing an additional 31 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.